You can find our latest publications here.

CBmed delegation visits partners in South Korea

From 15-Nov-2019 a CBmed delegation was visiting the Samsung Medical Center in Seoul. Together with one of its funding agencies, the SFG and their CEO Mag. Ludwig, our delegation had joint discussions with Prof. Nam. Do-Hyun Nam, a leading expert in drug screening of cancer patients, gave insights into the facilities at Samsung Medical Center. […]

SHIMADZU 7th Global Pharma Summit 2019 | Singapore

CBmed was invited from Shimadzu Headquarters to participate to their 7th Global Pharma summit in Singapore. Thomas Pieber along with other experts from industry and academia was representing CBmed at the final panel discussion.  

CBmed and Roche have signed large cooperation contracts for personalized medicine

On July 31, 2019, Roche Austria (Pharma) and Roche Diagnostics partnered with CBmed. The companies will be involved as partners in 2 COMET-funded projects.

International co-development for precision oncology

On 27.06.2019, CBmed GmbH and Aimed Bio Inc. joined hands in the field of precision oncology. Do-Hyun Nam (CEO and founder of Aimed Bio) and Robert Lobnig signed a Memorandum of Understanding that sets the stage for a long-term collaboration starting end of 2019 based on a COMET funded project in the cancer area. The […]

The COMET Center CBmed is funded within COMET – Competence Centers for Excellent Technologies by the Federal Ministry of Climate Action, Environment, Energy, Mobility, Innovation and Technology (BMK), the Federal Ministry for Digital and Economic Affairs (BMDW), Land Steiermark (Styrian Business Promotion Agency – SFG) and Land Wien (Vienna Business Agency – WAW). The COMET program is executed by the Austrian Research Promotion Agency (FFG).

CBmed GmbH Center for Biomarker Research in Medicine
Stiftingtalstrasse 5   8010 Graz   Austria   +43 316 385 28801